268 related articles for article (PubMed ID: 31830542)
1. Mitochondria-targeting nanomedicine self-assembled from GSH-responsive paclitaxel-ss-berberine conjugate for synergetic cancer treatment with enhanced cytotoxicity.
Cheng Y; Ji Y
J Control Release; 2020 Feb; 318():38-49. PubMed ID: 31830542
[TBL] [Abstract][Full Text] [Related]
2. Redox-sensitive carrier-free nanoparticles self-assembled by disulfide-linked paclitaxel-tetramethylpyrazine conjugate for combination cancer chemotherapy.
Zou L; Liu X; Li J; Li W; Zhang L; Fu C; Zhang J; Gu Z
Theranostics; 2021; 11(9):4171-4186. PubMed ID: 33754055
[No Abstract] [Full Text] [Related]
3. Triple stimuli-responsive supramolecular nanoassembly with mitochondrial targetability for chemophotothermal therapy.
Cheng Y; Ji Y; Tong J
J Control Release; 2020 Nov; 327():35-49. PubMed ID: 32781173
[TBL] [Abstract][Full Text] [Related]
4. Delivery of baicalein and paclitaxel using self-assembled nanoparticles: synergistic antitumor effect in vitro and in vivo.
Wang W; Xi M; Duan X; Wang Y; Kong F
Int J Nanomedicine; 2015; 10():3737-50. PubMed ID: 26045664
[TBL] [Abstract][Full Text] [Related]
5. Novel free-paclitaxel-loaded redox-responsive nanoparticles based on a disulfide-linked poly(ethylene glycol)-drug conjugate for intracellular drug delivery: synthesis, characterization, and antitumor activity in vitro and in vivo.
Chuan X; Song Q; Lin J; Chen X; Zhang H; Dai W; He B; Wang X; Zhang Q
Mol Pharm; 2014 Oct; 11(10):3656-70. PubMed ID: 25208098
[TBL] [Abstract][Full Text] [Related]
6. Pulmonary Delivery of Reactive Oxygen Species/Glutathione-Responsive Paclitaxel Dimeric Nanoparticles Improved Therapeutic Indices against Metastatic Lung Cancer.
Tian X; Bera H; Guo X; Xu R; Sun J; He Z; Cun D; Yang M
ACS Appl Mater Interfaces; 2021 Dec; 13(48):56858-56872. PubMed ID: 34806372
[TBL] [Abstract][Full Text] [Related]
7. Redox-responsive paclitaxel-pentadecanoic acid conjugate encapsulated human serum albumin nanoparticles for cancer therapy.
Zhang Y; Wang J; Xing H; Liu C; Li X
Int J Pharm; 2023 Mar; 635():122761. PubMed ID: 36822341
[TBL] [Abstract][Full Text] [Related]
8. Engineering Transferrin-Decorated Pullulan-Based Prodrug Nanoparticles for Redox Responsive Paclitaxel Delivery to Metastatic Lung Cancer Cells.
Zhao X; Guo H; Bera H; Jiang H; Chen Y; Guo X; Tian X; Cun D; Yang M
ACS Appl Mater Interfaces; 2023 Jan; 15(3):4441-4457. PubMed ID: 36633929
[TBL] [Abstract][Full Text] [Related]
9. α-Amylase- and Redox-Responsive Nanoparticles for Tumor-Targeted Drug Delivery.
Li Y; Hu H; Zhou Q; Ao Y; Xiao C; Wan J; Wan Y; Xu H; Li Z; Yang X
ACS Appl Mater Interfaces; 2017 Jun; 9(22):19215-19230. PubMed ID: 28513132
[TBL] [Abstract][Full Text] [Related]
10. Polymeric Nanomedicine for Combined Gene/Chemotherapy Elicits Enhanced Tumor Suppression.
Xu B; Xia S; Wang F; Jin Q; Yu T; He L; Chen Y; Liu Y; Li S; Tan X; Ren K; Yao S; Zeng J; Song X
Mol Pharm; 2016 Feb; 13(2):663-76. PubMed ID: 26695934
[TBL] [Abstract][Full Text] [Related]
11. Van der Waals force-driven indomethacin-ss-paclitaxel nanodrugs for reversing multidrug resistance and enhancing NSCLC therapy.
Kang W; Ji Y; Cheng Y
Int J Pharm; 2021 Jun; 603():120691. PubMed ID: 33965541
[TBL] [Abstract][Full Text] [Related]
12. A convenient protonated strategy for constructing nanodrugs from hydrophobic drug-inhibitor conjugates to reverse tumor multidrug resistance.
Wang P; Wang Y; Xia X; Wu J; Lin J; Huang W; Yan D
Nanoscale; 2024 May; 16(17):8434-8446. PubMed ID: 38592819
[TBL] [Abstract][Full Text] [Related]
13. Glucose-coated Berberine Nanodrug for Glioma Therapy through Mitochondrial Pathway.
Wang S; An J; Dong W; Wang X; Sheng J; Jia Y; He Y; Ma X; Wang J; Yu D; Jia X; Wang B; Yu W; Liu K; Zhao Y; Wu Y; Zhu W; Pan Y
Int J Nanomedicine; 2020; 15():7951-7965. PubMed ID: 33116511
[TBL] [Abstract][Full Text] [Related]
14. Paclitaxel-Paclitaxel Prodrug Nanoassembly as a Versatile Nanoplatform for Combinational Cancer Therapy.
Han X; Chen J; Jiang M; Zhang N; Na K; Luo C; Zhang R; Sun M; Lin G; Zhang R; Ma Y; Liu D; Wang Y
ACS Appl Mater Interfaces; 2016 Dec; 8(49):33506-33513. PubMed ID: 27960378
[TBL] [Abstract][Full Text] [Related]
15. Probing the fluorination effect on the self-assembly characteristics,
Wang X; Yang B; Li L; Liu T; Zuo S; Chi D; He Z; Sun B; Sun J
Theranostics; 2021; 11(16):7896-7910. PubMed ID: 34335971
[No Abstract] [Full Text] [Related]
16. Stimuli-responsive heparin-drug conjugates co-assembled into stable nanomedicines for cancer therapy.
Fang Z; Lin L; Li Z; Gu L; Pan D; Li Y; Chen J; Ding H; Tian X; Gong Q; Luo K
Acta Biomater; 2023 Jul; 164():422-434. PubMed ID: 37088159
[TBL] [Abstract][Full Text] [Related]
17. Self-Assembly of Porphyrin-Paclitaxel Conjugates Into Nanomedicines: Enhanced Cytotoxicity due to Endosomal Escape.
Zheng X; Li Z; Chen L; Xie Z; Jing X
Chem Asian J; 2016 Jun; 11(12):1780-4. PubMed ID: 27124552
[TBL] [Abstract][Full Text] [Related]
18. Berberine and folic acid co-modified pH-sensitive cascade-targeted PTX-liposomes coated with Tween 80 for treating glioma.
Yang C; Yang Z; Wang S; Chen J; Liu Q; Tianle Huang ; Hai L; Lu R; Wu Y
Bioorg Med Chem; 2022 Sep; 69():116893. PubMed ID: 35752143
[TBL] [Abstract][Full Text] [Related]
19. Reconstituted high density lipoprotein mediated targeted co-delivery of HZ08 and paclitaxel enhances the efficacy of paclitaxel in multidrug-resistant MCF-7 breast cancer cells.
Zhang F; Wang X; Xu X; Li M; Zhou J; Wang W
Eur J Pharm Sci; 2016 Sep; 92():11-21. PubMed ID: 27343697
[TBL] [Abstract][Full Text] [Related]
20. Redox-sensitive mPEG-SS-PTX/TPGS mixed micelles: An efficient drug delivery system for overcoming multidrug resistance.
Zhao D; Zhang H; Yang S; He W; Luan Y
Int J Pharm; 2016 Dec; 515(1-2):281-292. PubMed ID: 27746331
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
